KLP Kapitalforvaltning’s Ultragenyx Pharmaceutical RARE Stock Holding History

KLP Kapitalforvaltning’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$651K	Hold	19,500	–	–	﹤0.01%	1384
2026 Q1	$409K	Buy	19,500 +1,000	+5%	+$22.5K	﹤0.01%	1513
2025 Q4	$426K	Buy	18,500 +800	+5%	+$26.3K	﹤0.01%	1493
2025 Q3	$532K	Hold	17,700	–	–	﹤0.01%	1367
2025 Q2	$644K	Buy	17,700 +1,400	+9%	+$50.5K	﹤0.01%	1221
2025 Q1	$590K	Hold	16,300	–	–	﹤0.01%	1210
2024 Q4	$686K	Buy	+16,300	New	+$809K	﹤0.01%	1177

Other funds holding RARE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

KLP Kapitalforvaltning's RARE Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Ultragenyx Pharmaceutical (RARE) position steady in Q2 2026 at 19,500 shares worth $651K. The position accounts for ﹤0.01% of the portfolio, ranked #1384.

KLP Kapitalforvaltning first reported a position in RARE in Q4 2024 and has held it in 7 quarters since. The position peaked at $686K in Q4 2024. 311 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

KLP Kapitalforvaltning held 19,500 shares of Ultragenyx Pharmaceutical worth $651K as of Q2 2026.
KLP Kapitalforvaltning left its Ultragenyx Pharmaceutical share count unchanged in Q2 2026.
Ultragenyx Pharmaceutical made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1384 holding.
KLP Kapitalforvaltning first reported a position in Ultragenyx Pharmaceutical in Q4 2024 and has held it in 7 quarters since.
KLP Kapitalforvaltning's Ultragenyx Pharmaceutical position peaked at $686K in Q4 2024.
311 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.